NCT01581060 2014-05-16Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid TumoursHeidelberg Pharma AGPhase 1/2 Terminated41 enrolled